Zurich Cantonal Bank
IART icon

Zurich Cantonal Bank’s Integra LifeSciences IART Stock Holding History

Zurich Cantonal Bank’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Hold
28,785
– – ﹤0.01% 1919
2026
Q1 		$271K Buy
+28,785
New +$316K ﹤0.01% 2139
2025
Q4 		– Sell
-19,014
Closed -$253K – 2999
2025
Q3 		$272K Hold
19,014
– – ﹤0.01% 2047
2025
Q2 		$233K Buy
19,014
+2,203
+13% +$32K ﹤0.01% 2059
2025
Q1 		$370K Buy
16,811
+2,357
+16% +$55.4K ﹤0.01% 1779
2024
Q4 		$328K Hold
14,454
– – ﹤0.01% 1881
2024
Q3 		$263K Hold
14,454
– – ﹤0.01% 1962
2024
Q2 		$421K Buy
14,454
+1,010
+8% +$30K ﹤0.01% 1604
2024
Q1 		$477K Sell
13,444
-2,724
-17% -$109K ﹤0.01% 1486
2023
Q4 		$704K Buy
16,168
+1,896
+13% +$74.6K ﹤0.01% 1271
2023
Q3 		$545K Buy
14,272
+1,946
+16% +$81.9K ﹤0.01% 1340
2023
Q2 		$507K Buy
12,326
+674
+6% +$32.4K ﹤0.01% 1338
2023
Q1 		$669K Buy
11,652
+1,547
+15% +$87.2K ﹤0.01% 1123
2022
Q4 		$567K Buy
10,105
+804
+9% +$40.9K ﹤0.01% 1182
2022
Q3 		$394K Buy
9,301
+943
+11% +$48.3K ﹤0.01% 1346
2022
Q2 		$452K Sell
8,358
-1,316
-14% -$79K ﹤0.01% 1289
2022
Q1 		$622K Sell
9,674
-1,588
-14% -$105K ﹤0.01% 1212
2021
Q4 		$754K Buy
11,262
+4,283
+61% +$290K ﹤0.01% 1168
2021
Q3 		$478K Hold
6,979
– – ﹤0.01% 1329
2021
Q2 		$476K Sell
6,979
-513
-7% -$36.3K ﹤0.01% 1256
2021
Q1 		$518K Sell
7,492
-1,133
-13% -$76.8K ﹤0.01% 1210
2020
Q4 		$560K Buy
8,625
+670
+8% +$36.1K ﹤0.01% 1217
2020
Q3 		$376K Hold
7,955
– – ﹤0.01% 1222
2020
Q2 		$374K Buy
7,955
+1,772
+29% +$87.1K ﹤0.01% 1156
2020
Q1 		$276K Buy
6,183
+849
+16% +$44.6K ﹤0.01% 1073
2019
Q4 		$311K Buy
5,334
+753
+16% +$44.8K ﹤0.01% 1102
2019
Q3 		$275K Buy
4,581
+360
+9% +$21.4K ﹤0.01% 1095
2019
Q2 		$236K Hold
4,221
– – ﹤0.01% 1156
2019
Q1 		$235K Sell
4,221
-850
-17% -$43.3K ﹤0.01% 1120
2018
Q4 		$229K Buy
5,071
+412
+9% +$22.6K ﹤0.01% 1133
2018
Q3 		$307K Buy
4,659
+310
+7% +$19.3K ﹤0.01% 1080
2018
Q2 		$280K Buy
4,349
+543
+14% +$33.6K ﹤0.01% 1076
2018
Q1 		$211K Hold
3,806
– – ﹤0.01% 1168
2017
Q4 		$182K Buy
3,806
+1,054
+38% +$51.6K ﹤0.01% 1238
2017
Q3 		$139K Hold
2,752
– – ﹤0.01% 1194
2017
Q2 		$150K Buy
2,752
+218
+9% +$10.4K ﹤0.01% 1125
2017
Q1 		$107K Buy
2,534
+968
+62% +$41.4K ﹤0.01% 1303
2016
Q4 		$67K Hold
1,566
– – ﹤0.01% 1540
2016
Q3 		$65K Buy
1,566
+240
+18% +$10.1K ﹤0.01% 1500
2016
Q2 		$53K Hold
1,326
– – ﹤0.01% 1470
2016
Q1 		$45K Hold
1,326
– – ﹤0.01% 1484
2015
Q4 		$45K Buy
1,326
+416
+46% +$13K ﹤0.01% 1504
2015
Q3 		$27K Buy
910
+678
+292% +$21.2K ﹤0.01% 1402
2015
Q2 		$6K Hold
232
– – ﹤0.01% 1759
2015
Q1 		$6K Buy
+232
New +$5.48K ﹤0.01% 1730
2013
Q4 		– Sell
-97,859
Closed -$1.61M – 986
2013
Q3 		$1.61M Hold
97,859
– – 0.06% 353
2013
Q2 		$1.47M Buy
+97,859
New +$1.43M 0.05% 335

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Zurich Cantonal Bank's IART Position: Q2 2026 in Review

Zurich Cantonal Bank held its Integra LifeSciences (IART) position steady in Q2 2026 at 28,785 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Zurich Cantonal Bank first reported a position in IART in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.61M in Q3 2013. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Zurich Cantonal Bank held 28,785 shares of Integra LifeSciences worth $517K as of Q2 2026.
  • Zurich Cantonal Bank left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1919 holding.
  • Zurich Cantonal Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 47 quarters since.
  • Zurich Cantonal Bank's Integra LifeSciences position peaked at $1.61M in Q3 2013.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.